MEDIAN TECHNOLOGIES

median-technologies-logo

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.

#SimilarOrganizations #People #Financial #Event #Website #More

MEDIAN TECHNOLOGIES

Social Links:

Industry:
Clinical Trials Health Care Pharmaceutical

Founded:
2002-01-01

Address:
Valbonne, Provence-Alpes-Cote D'Azur, France

Country:
France

Website Url:
http://www.mediantechnologies.com

Total Employee:
101+

Status:
Active

Contact:
+330493333777

Email Addresses:
[email protected]

Total Funding:
122.89 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Domain Not Resolving


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

auris-medical-logo

Auris Medical

Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.

bc-platforms-logo

BC Platforms

BC Platforms is a fast-growing data and technology company advancing Personalized Medicine and Precision Medicine.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

mytomorrows-logo

myTomorrows

myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.

parnell-living-science-logo

Parnell Living Science

Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.


Current Advisors List

gerard-milhiet_image

Gerard Milhiet Member of the Board of Directors @ Median Technologies
Board_member

fredrik-brag_image

Fredrik Brag Chairman of the Board of Directors @ Median Technologies
Board_member
2003-01-01

otello-stampacchia_image

Otello Stampacchia Board Member @ Median Technologies
Board_member

oran-muduroglu_image

Oran Muduroglu Member of The Board of Directors @ Median Technologies
Board_member

jacques-souquet_image

Jacques Souquet Board of Directors @ Median Technologies
Board_member

Current Employees Featured

fredrik-brag_image

Fredrik Brag
Fredrik Brag Co-Founder & CEO @ Median Technologies
Co-Founder & CEO
2003-01-01

jean-christophe-montigny_image

Jean-Christophe Montigny
Jean-Christophe Montigny CFO @ Median Technologies
CFO
2021-07-01

Founder


arnaud-butzbach_image

Arnaud Butzbach

fredrik-brag_image

Fredrik Brag

gerard-milhiet_image

Gerard Milhiet

Stock Details


Company's stock symbol is EPA:ALMDT

Investors List

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - Median Technologies

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Median Technologies

abingworth-management_image

Abingworth

Abingworth investment in Post-IPO Equity - Median Technologies

omega-funds_image

Omega Funds

Omega Funds investment in Post-IPO Equity - Median Technologies

abingworth-management_image

Abingworth

Abingworth investment in Post-IPO Equity - Median Technologies

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Median Technologies

idinvest-partners_image

Idinvest Partners

Idinvest Partners investment in Post-IPO Equity - Median Technologies

threshold_image

Threshold

Threshold investment in Post-IPO Equity - Median Technologies

auriga-partners_image

Auriga Partners

Auriga Partners investment in Post-IPO Equity - Median Technologies

omega-funds_image

Omega Funds

Omega Funds investment in Post-IPO Equity - Median Technologies

Official Site Inspections

http://www.mediantechnologies.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.93 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Median Technologies" on Search Engine